Better health and ageing for all Australians

Public Summary Documents by Meeting

PBAC Public Summary Documents - March 2006

Public Summary Documents relating to the March 2006 PBAC Meeting.

In this section:

Adalimumab, pre-filled syringe, 40 mg per 0.8 mL, Humira®

Alendronate Sodium with Colecalciferol (vitamin D3), tablet, 70 mg-70 micrograms (2800 i.u.), Fosamax® Plus

Anecortave acetate, depot suspension, 15 mg in 0.5 mL, Retaane®

Aprepitant, capsule, 1 x125 mg and 2 x 80 mg Tri - pack, Emend®

Blood beta-ketone, electrode strips, MediSense Optium® Ketone Blood β-Ketone Electrodes®

Bortezomib, powder for I.V. injection, 3.5 mg, Velcade®

Carmustine, implant, 7.7 mg, Gliadel®

Docetaxel, injection set containing 1 single use vial concentrate for I.V. infusion, 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL and 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL, Taxotere®

Epoprostenol Sodium, injection set containing 1 vial powder for I.V. infusion 500 micrograms and 1 vial diluent 50 mL, injection set containing 1 vial powder for I.V. infusion 1.5 mg and 2 vials diluent 50 mL, Flolan®

Erlotinib hydrochloride, tablet, 25 mg, 100 mg and 150 mg (base), Tarceva®

Etanercept, injection set containing 4 vials powder for injection 25 mg or 50 mg and 4 pre-filled syringes solvent 1 mL, Enbrel®

Fentanyl citrate, lozenge with integral applicator, 200 microgram, 400 microgram, 600 microgram, 800 microgram, 1200 microgram and 1600 microgram, Actiq®

Fentanyl, transdermal patch, releasing approximately 12, 25, 50, 75 or 100 micrograms per hour, Durogesic® 12/25/50/75/100

Ferrous fumurate with folic acid, tablet, 310 mg – 350 micrograms, Ferro-F-Tab®

Hylan G-F 20, injection, 16 mg in 2 mL, Synvisc®

Infliximab, powder for intravenous infusion, 100 mg, Remicade®

Insulin detemir (rys) cartridge 3mL (Penfill®), prefilled device 3 mL, (FlexPen®), 100 U/mL, Levemir®, March 2006

Insulin glargine, injection, 100 units per mL, 10 mL vials and 3 mL x 5 cartridges, Lantus®, March 2006

Methylphenidate hydrochloride, extended release tablets, 18 mg, 36 mg and 54 mg, Concerta®

Moxonidine, tablets, 200 microgram and 400 microgram, Physiotens®

Paclitaxel, solution concentrate for I.V. infusion, 30 mg in 5 mL, 100mg in 16.7 mL, 150 mg in 25 mL and 300 mg in 50 mL, Anzatax®

Pertussis vaccine acellular with Diphtheria and Tetanus Toxoids, adsorbed, injection, 0.5 mL, Adacel®

Risperidone, powder for I.M. injection, 25 mg, 37.5 mg and 50 mg (modified release) with 2 mL diluent in pre-filled syringe, Risperdal Consta®

Rituximab, solution for I.V. infusion, 100 mg in 10 mL and 500 mg in

Ropinirole, tablets, 0.25 mg, 0.5 mg and 2 mg, Repreve®

Sevelamer hydrochloride, tablets, 800 mg, Renagel®

Sibutramine hydrochloride, capsules, 10 mg and 15 mg, Reductil/Ectiva®

Teriparatide, solution for injection, in a 3mL cartridge contained in a pre-filled disposable delivery device (pen), 250 micrograms/mL, Forteo®

Vinorelbine tartrate, soft capsule, 20 mg and 30 mg (base), Navelbine®